← Eichor
Study identifier: NCT05186623 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prediction Model for Response to Biologics and Small Molecular Agent for UC

Condition: Ulcerative Colitis  ·  Sponsor: Asan Medical Center

PhaseN/A
Planned participants300
Who can joinAll sexes, 18 Years to 79 Years
Healthy volunteersNo

About this study

This prospective observational study is going to develop and validate a prediction model of response to biologic agents and small molecular agents for Korean patients with ulcerative colitis.

This description comes directly from the study's public registry record.

Talk to the study team

Byong Duk Ye, MD, PhD  ·  82230103180  ·  bdye@amc.seoul.kr

Always discuss trial participation with your own doctor first.

Locations (1)

Asan Medical CenterSeoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05186623